About Windlas Biotech
Windlas Biotech is a Mainboard IPO with an issue size of ₹401.54 crore, proposed for listing on BSE, NSE. The offer opens on 4th Aug 2021 and closes on 6th Aug 2021. The issue structure includes a fresh issue of ₹165.00 crore and an offer-for-sale component of ₹236.54 crore. The current listing schedule points to 16th Aug 2021.
Company Contact
Address—
Phone—
Websitehttps://www.ipomatrix.com/